Tang Li, Wang Xi, Zhao Rong, Chen Xiaomei, Wang Feixia, Xia Siwei, Xiao Qian, Zhao Qiang, Yang Shiyan, Tan Shanzhong
Department of Integrated TCM and Western Medicine, Nanjing Hospital Affiliated to Nanjing University of Chinese Medicine, Nanjing, 210003, China; Department of Gastroenterology, Nanjing Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing, 210022, China.
Department of Integrated TCM and Western Medicine, Nanjing Hospital Affiliated to Nanjing University of Chinese Medicine, Nanjing, 210003, China.
J Ethnopharmacol. 2023 May 23;308:116276. doi: 10.1016/j.jep.2023.116276. Epub 2023 Feb 17.
A key event in the pathogenesis of acute-on-chronic liver failure (ACLF) is the imbalance in the systemic immune response; immunosuppression in patients with ACLF contributes to poor prognosis. The Yi-Qi-Jian-Pi formula (YQJPF) may improve T lymphocyte immune function in patients with ACLF.
To investigate the immune mechanism of YQJPF in vivo and in vitro.
An ACLF rat model was established by injection of CCl, lipopolysaccharide, and D-galactosamine. We examined the effect of different doses of YQJPF (6.43, 12.87, 25.74 g/kg) on liver injury and immune function in the ACLF rat model. Magnetic-activated cell sorting was used to sort the CD8 T lymphocytes in the spleen for lymphocyte function detection. In primary CD8 T lymphocytes and Jurkat cell lines, the expression of mitochondrial function and biogenesis and autophagy related markers were detected using molecular biological methods and flow cytometry analysis.
YQJPF improved the peripheral blood lymphocyte count and proportion of CD8 T lymphocytes in ACLF rats, increased pro-inflammatory factors (IL-2, IFN-λ, and TNF-α), and reduced anti-inflammatory factors (IL-10 and TGF β1). YQJPF also improved metabolism and mitochondrial homeostasis in CD8 T lymphocytes, alleviated lymphocyte immune dysfunction by promoting autophagy, upregulated mitochondrial biogenesis by promoting PGC-1α, NRF-1, and TFAM expression, and regulated the relationship between autophagy and mitochondrial biogenesis via PGC-1α.
Our results suggest that YQJPF could improve immune function in a rat model of ACLF, possibly via affecting the homeostasis of lymphatic mitochondria in CD8 T lymphocytes. YQJPF may enhance lymphocyte mitochondrial biosynthesis and promote lymphocyte autophagy. PGC-1α is a possible upstream regulatory target of YQJPF.
慢加急性肝衰竭(ACLF)发病机制中的一个关键事件是全身免疫反应失衡;ACLF患者的免疫抑制导致预后不良。益气健脾方(YQJPF)可能改善ACLF患者的T淋巴细胞免疫功能。
探讨YQJPF在体内和体外的免疫机制。
通过注射四氯化碳、脂多糖和D-半乳糖胺建立ACLF大鼠模型。我们研究了不同剂量的YQJPF(6.43、12.87、25.74 g/kg)对ACLF大鼠模型肝损伤和免疫功能的影响。采用磁激活细胞分选技术分选脾脏中的CD8 T淋巴细胞进行淋巴细胞功能检测。在原代CD8 T淋巴细胞和Jurkat细胞系中,使用分子生物学方法和流式细胞术分析检测线粒体功能、生物发生和自噬相关标志物的表达。
YQJPF改善了ACLF大鼠外周血淋巴细胞计数和CD8 T淋巴细胞比例,增加了促炎因子(IL-2、IFN-λ和TNF-α),并降低了抗炎因子(IL-10和TGF β1)。YQJPF还改善了CD8 T淋巴细胞的代谢和线粒体稳态,通过促进自噬减轻淋巴细胞免疫功能障碍,通过促进PGC-1α、NRF-1和TFAM表达上调线粒体生物发生,并通过PGC-1α调节自噬与线粒体生物发生之间的关系。
我们的结果表明,YQJPF可能通过影响CD8 T淋巴细胞中淋巴线粒体的稳态来改善ACLF大鼠模型的免疫功能。YQJPF可能增强淋巴细胞线粒体生物合成并促进淋巴细胞自噬。PGC-1α可能是YQJPF的上游调控靶点。